INNV Stock Overview
Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for INNV from our risk checks.
My Notes
Capture your thoughts, links and company narrative
InnovAge Holding Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.19 |
| 52 Week High | US$6.69 |
| 52 Week Low | US$3.52 |
| Beta | 0.31 |
| 1 Month Change | -14.31% |
| 3 Month Change | -29.22% |
| 1 Year Change | -21.24% |
| 3 Year Change | -21.09% |
| 5 Year Change | n/a |
| Change since IPO | -82.69% |
Recent News & Updates
Recent updates
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
Nov 07
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
Aug 20InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story
Jun 28Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)
May 07InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?
Mar 15Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)
Jan 06InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price
Aug 10Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely
Jun 08InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M
Sep 13InnovAge names Richard Feifer as chief medical officer
Aug 17InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital
Jul 27Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts
May 12Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital
Apr 14Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?
Mar 24InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth
Mar 19InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors
Nov 16Are Investors Undervaluing InnovAge Holding Corp. (NASDAQ:INNV) By 48%?
Jul 28Shareholder Returns
| INNV | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -5.6% | -4.1% | -2.4% |
| 1Y | -21.2% | -10.2% | 23.3% |
Return vs Industry: INNV underperformed the US Healthcare industry which returned -10.2% over the past year.
Return vs Market: INNV underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| INNV volatility | |
|---|---|
| INNV Average Weekly Movement | 8.7% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: INNV has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: INNV's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 2,350 | Patrick Blair | www.innovage.com |
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
InnovAge Holding Corp. Fundamentals Summary
| INNV fundamental statistics | |
|---|---|
| Market cap | US$567.56m |
| Earnings (TTM) | -US$15.96m |
| Revenue (TTM) | US$786.51m |
0.7x
P/S Ratio-35.6x
P/E RatioIs INNV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INNV income statement (TTM) | |
|---|---|
| Revenue | US$786.51m |
| Cost of Revenue | US$236.92m |
| Gross Profit | US$549.59m |
| Other Expenses | US$565.56m |
| Earnings | -US$15.96m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 69.88% |
| Net Profit Margin | -2.03% |
| Debt/Equity Ratio | 22.2% |
How did INNV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:47 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
InnovAge Holding Corp. is covered by 15 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Steven Valiquette | Barclays |
| Sarah James | Barclays |